Definigen Investors
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
Investors
%20.jpg)
%20.jpg)
Founded Date:
2012
Number Of Exists:
Venture - Series Unknown
Employee Number:
11-50
Industry:
Healthcare Innovations
Investor Type:
Healthcare Company